ArticleTherapeutic advances in gastroenterology2025

Quality of life and burden of disease in a Mexican population with inflammatory bowel disease: an analysis of the RISE-MX trial.

Rosa M Miranda-Cordero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.